Vlaio
Government · Belgium · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Koning Albert Ii-laan 35 Bus 12, Bruxell...Phone Number
+32 24324244Website
www.vlaio.beRevenue
$17 MillionIndustry
About Vlaio
Is Vlaio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Vlaio launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Vlaio has new funding data
Check out if Vlaio is spiking on competitors!
Click to see if Vlaio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Vlaio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Vlaio
Vlaio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Vlaio recently announced quarterly report
Recommended Actions
Find VP level buyers at Vlaio
Find 3 more new buyers
Company Profile Activity
Activity Insights
Vlaio is experiencing very low activity levels compared to other companies in the Government sector.
What does this means?
Vlaio is drawing exceptional interest within the Government industry, suggesting notable developments or strong market momentum, learn more about Vlaio.
Vlaio Tech Stack
A closer look at the technologies used by Vlaio
Most Recent Scoops
Vlaio News & Media
AstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccine
Leuven, Belgium, December 12, 2023 – AstriVax is pleased to announce that it has been selected for funding by Flanders Innovation & Entrepreneurship (VLAIO). The company has received a grant of €3 million to advance its innovative technology in clinical development for one of the lead indications, chronic Hepatitis B.AstriVax Awarded €2.5 Million Grant to Advance Innovative Vaccine Platform
Leuven, Belgium, May 30, 2023 – AstriVax is pleased to announce that it has been selected for funding by Flanders Innovation & Entrepreneurship (VLAIO). The company has received a grant of €2.5 million to advance its innovative technology.Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics
LEUVEN, BELGIUM, June 14, 2021 /EINPresswire.com/ -- Montis Biosciences, a Belgium-based biotech company focused on the development of novel immuno-oncology therapeutics targeting the interactions between perivascular macrophages and the tumor …Pulsify Medical closes second round Series A funding of EUR 5.4 million for wearable ultrasound ...
Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart.
Top Government Companies
Frequently Asked Questions Regarding Vlaio
The Agency for Innovation and Entrepreneurship (VLAIO) is an organisation of the Flemish government for all entrepreneurs in Flanders. In 2016, the previously existing agencies Enterprise Flanders and the company-directed activities of IWT were merged into VLAIO. The research activities of IWT were taken over by the Flemish Research Council (FWO).... Read More